University of Texas Health Science Center at Houston (UTHealth)

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study (2017) Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, Wade KH, et al. Journal article Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study (2016) Dixon SC, Nagle CM, Thrift AP, Pharoah PDP, Pearce CL, Zheng W, Painter JN, et al. Journal article Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies (2016) Lopez-Isac E, Martin JE, Assassi S, Simeon CP, Carreira P, Ortego-Centeno N, Freire M, et al. Journal article, Report Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway (2016) Lopez-Isac E, Campillo-Davo D, Bossini-Castillo L, Guerra SG, Assassi S, Pilar Simeon C, Carreira P, et al. Journal article KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference (2016) Schumann G, Liu C, O'Reilly P, Gao H, Song P, Xu B, Ruggeri B, et al. Journal article Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium (2015) Johnatty SE, Tyrer JP, Kar S, Beesley J, Lu Y, Gao B, Fasching P, et al. Journal article Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer (2015) Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, et al. Journal article Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis (2015) Ochoa E, Martin JE, Assassi S, Beretta L, Carreira P, Guillen A, Simeon CP, et al. Journal article Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial (2015) Schellinger PD, Alexandrov AV, Barreto AD, Demchuk AM, Tsivgoulis G, Köhrmann M, Alleman J, et al. Journal article Inactivating mutations in NPC1L1 and protection from coronary heart disease (2014) Stitziel NO, Won HH, Morrison AC, Peloso GM, Do R, Lange LA, Fontanillas P, et al. Journal article